Evaluation of Efficacy and Safety of Two New Formulations Compared to Gynomax® XL Ovule
Status:
Completed
Trial end date:
2021-08-26
Target enrollment:
Participant gender:
Summary
Efficacy and safety of two new formulations compared to Gynomax® XL ovule in the treatment of
trichomonal vaginitis, bacterial vaginosis, candidal vulvovaginitis and mixed vaginal
infections was evaluated in this randomized, three-arms, multicentral study.